How to Find an Adult Metabolic Clinic for PKU
At a Glance
To find an adult metabolic clinic for PKU, ask your pediatric doctor for a direct referral or use the National PKU Alliance (NPKUA) directory. Securing specialized adult care ensures uninterrupted access to necessary prescriptions, regular blood monitoring, and protects your brain health.
Transitioning from a pediatric metabolic clinic to adult care is a major milestone, but it is also a known vulnerability point where many patients with phenylketonuria (PKU, an inherited disorder that increases the levels of a substance called phenylalanine in the blood) accidentally drop out of the healthcare system [1]. To find a doctor who treats adults with PKU, the best first step is to ask your current pediatric clinic for a direct referral. You can also search the clinic directory provided by the National PKU Alliance (NPKUA) to find specialized adult metabolic centers in your area. Start this conversation early—ideally around age 16 or 18—so you have plenty of time to build your new care team before you officially age out of pediatric care.
The Importance of the “Warm Handoff”
As you age out of pediatric care, a coordinated transition is essential to minimize health risks and prevent disruptions in your treatment [1][2]. A “warm handoff” means your pediatric team directly connects you with an adult provider, forwarding your medical history, genetic test results, and current prescriptions. This coordination helps adult providers understand your unique baseline, encourages your independence as an adult patient, and ensures you do not experience a gap in accessing essential therapies [2].
Why Specialized Care is Essential
Adults with PKU face unique challenges and require consistent care in specialized medical centers [2][3]. Dropping out of the healthcare system or relying on a general practitioner who is unfamiliar with metabolic disorders carries significant risks:
- Continuous Prescriptions: Specialized care is necessary to maintain access to crucial prescriptions, including medical foods (specialized low-protein formula) and pharmaceuticals like sapropterin or pegvaliase [4][5].
- Blood Monitoring: Regular monitoring of your blood phenylalanine (Phe) levels remains mandatory in adulthood [4]. While testing is often recommended to be at least monthly, your specific clinic will set your schedule. Unfortunately, many adults receive less frequent monitoring than international guidelines recommend [6][7].
- Protecting Brain Health: Elevated blood Phe levels in adulthood are directly linked to cognitive impairments, including reduced processing speed and executive function, as well as changes to the brain’s physical structure [8][9][10]. Maintaining blood Phe levels at or below 360 μmol/L throughout life is strongly recommended by US guidelines to protect your intellectual functioning [11]. Depending on where you live, regional guidelines (such as in Europe) might allow for slightly higher targets, so you should always ask your new provider what your specific goal should be.
- Managing Overall Health: Adults with PKU have a higher risk of developing other health conditions than the general population, such as obesity and dental problems [2][12][13]. Poorly managed Phe levels are also associated with a lower quality of life and increased anxiety [12][14].
- Family Planning: For females with PKU, specialized metabolic centers provide vital preconception training to ensure strict metabolic control before and during pregnancy. With proper management, healthy pregnancies are entirely possible and maternal PKU syndrome can be prevented [15][11]. For all adults, including men, genetic counseling can help you understand the chances of passing the PKU trait to your children.
Steps for Finding Your Adult Clinic
- Talk to Your Current Dietitian and Doctor: Ask them exactly when you will “age out” of their practice and request a referral to an adult metabolic specialist.
- Consult the NPKUA Clinic Directory: The National PKU Alliance maintains an active list of metabolic clinics. Look for centers that explicitly state they treat adult patients.
- Explore Telehealth or Co-Management: If you live in an area without a nearby adult clinic, do not panic. Many metabolic specialists offer telehealth appointments, or they can partner with a local primary care doctor to help co-manage your treatment from a distance.
- Verify Insurance Coverage: Transitioning to adult care often happens around the same time young adults transition to their own health insurance. Ensure the new clinic and your prescribed medical foods and medications are covered under your plan [16][17].
Common questions in this guide
When should I start planning my transition to an adult PKU clinic?
What if there isn't an adult metabolic clinic near me?
Why do adults with PKU still need specialized care?
What is the target blood phenylalanine level for adults with PKU?
How do I ensure my medical foods are covered when switching to adult care?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.At what age will I need to officially transition out of this pediatric clinic, and when should we start the handover process?
- 2.Can you provide a direct referral to a specific adult metabolic clinic and forward my complete medical history?
- 3.What paperwork or prior authorizations will I need to ensure my medical food and prescriptions are uninterrupted during the transition?
- 4.If there isn't an adult clinic close to me, would you be willing to partner with a distant metabolic specialist via telehealth to help co-manage my care?
- 5.For my new adult provider: How many adult PKU patients do you currently treat, and what are your clinic's specific guidelines for my target phenylalanine levels?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (17)
- 1
Adult patient perspectives on phenylketonuria care: Highlighting the need for dedicated adult management and services.
Suddaby JS, Sohaei D, Bell H, et al.
European journal of medical genetics 2020; (63(4)):103818 doi:10.1016/j.ejmg.2019.103818.
PMID: 31778858 - 2
Health status and comorbidities of adult patients with phenylketonuria (PKU) in France with a focus on early-diagnosed patients - A nationwide study of health insurance claims data.
Charrière S, Maillot F, Bouée S, et al.
Molecular genetics and metabolism 2023; (139(3)):107625 doi:10.1016/j.ymgme.2023.107625.
PMID: 37329624 - 3
Prevalence of comorbid conditions among adult patients diagnosed with phenylketonuria.
Burton BK, Jones KB, Cederbaum S, et al.
Molecular genetics and metabolism 2018; (125(3)):228-234 doi:10.1016/j.ymgme.2018.09.006.
PMID: 30266197 - 4
Current Insights into Nutritional Management of Phenylketonuria: An Update for Children and Adolescents.
Anton-Păduraru DT, Trofin F, Chis A, et al.
Children (Basel, Switzerland) 2025; (12(2)) doi:10.3390/children12020199.
PMID: 40003301 - 5
First 1.5 years of pegvaliase clinic: Experiences and outcomes.
Sacharow S, Papaleo C, Almeida K, et al.
Molecular genetics and metabolism reports 2020; (24()):100603 doi:10.1016/j.ymgmr.2020.100603.
PMID: 32489881 - 6
Adult PKU Clinics in the UK-Users' Experiences and Perspectives.
Ilgaz F, Ford S, O'Driscoll MF, MacDonald A
Nutrients 2023; (15(20)) doi:10.3390/nu15204352.
PMID: 37892429 - 7
Management of phenylketonuria in European PKU centres remains heterogeneous.
Ahring K, Bélanger-Quintana A, Burlina A, et al.
Molecular genetics and metabolism 2024; (141(1)):108120 doi:10.1016/j.ymgme.2023.108120.
PMID: 38159545 - 8
Long-term cognitive and psychosocial outcomes in adults with phenylketonuria.
Aitkenhead L, Krishna G, Ellerton C, et al.
Journal of inherited metabolic disease 2021; (44(6)):1353-1368 doi:10.1002/jimd.12413.
PMID: 34145605 - 9
Phenylalanine Effects on Brain Function in Adult Phenylketonuria.
Pilotto A, Zipser CM, Leks E, et al.
Neurology 2021; (96(3)):e399-e411 doi:10.1212/WNL.0000000000011088.
PMID: 33093221 - 10
Executive functions & metabolic control in phenylketonuria (PKU) and mild hyperphenylalaninemia (mHPA).
Tomm A, Thiele AG, Rohde C, et al.
Molecular genetics and metabolism 2024; (143(1-2)):108544 doi:10.1016/j.ymgme.2024.108544.
PMID: 39059271 - 11
Phenylalanine hydroxylase deficiency diagnosis and management: A 2023 evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG).
Smith WE, Berry SA, Bloom K, et al.
Genetics in medicine : official journal of the American College of Medical Genetics 2025; (27(1)):101289 doi:10.1016/j.gim.2024.101289.
PMID: 39630157 - 12
Systematic literature review of the somatic comorbidities experienced by adults with phenylketonuria.
Whitehall KB, Rose S, Clague GE, et al.
Orphanet journal of rare diseases 2024; (19(1)):293 doi:10.1186/s13023-024-03203-z.
PMID: 39135125 - 13
Dietary and metabolic effects on the oral status of patients with phenylketonuria: a nation-based cross-sectional study.
Bingöl AC, Bingöl M, Pandis N, et al.
Clinical oral investigations 2023; (27(5)):1981-1991 doi:10.1007/s00784-022-04827-w.
PMID: 36805804 - 14
Quality of life in children living with PKU - a single-center, cross-sectional, observational study from Hungary.
Becsei D, Hiripi R, Kiss E, et al.
Molecular genetics and metabolism reports 2021; (29()):100823 doi:10.1016/j.ymgmr.2021.100823.
PMID: 34900594 - 15
Preventing maternal phenylketonuria (PKU) syndrome: important factors to achieve good metabolic control throughout pregnancy.
Rohde C, Thiele AG, Baerwald C, et al.
Orphanet journal of rare diseases 2021; (16(1)):477 doi:10.1186/s13023-021-02108-5.
PMID: 34794480 - 16
Health economic impact of patients with phenylketonuria (PKU) in France - A nationwide study of health insurance claims data.
Arnoux JB, Douillard C, Maillot F, et al.
Molecular genetics and metabolism reports 2024; (41()):101134 doi:10.1016/j.ymgmr.2024.101134.
PMID: 39253300 - 17
Evaluating the Influence of Social Determinants of Health on Blood Phenylalanine Levels in Phenylketonuria Patients.
Afseth C, Knutsen J, Lamborn T, et al.
American journal of medical genetics. Part A 2025; (197(2)):e63885 doi:10.1002/ajmg.a.63885.
PMID: 39305121
This page is for informational purposes only and does not replace professional medical advice. Always consult your pediatric and adult care teams to ensure a safe and medically appropriate transition of your PKU treatment.
Get notified when new evidence is published on Phenylketonuria.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.